Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONICOV: Immune Response Monitoring in COVID-19 Patients
NCT04373200Completed
- Sponsor
- CHU Rennes
- Start
- May 2020
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by CHU Rennes. Primary endpoints: Number of increased immune population at Month 4, Number of decreased immune population at Month 4 and 1 more. Started May 2020; status: completed.
Beyond the preview
Go deeper on NCT04373200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04373200.